BLFS EBITDA | BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) EBITDA

2026-06-30: Basis Reported; EBITDA $2.11M*; Operating income $1.70M; Depreciation and amortization $411.00K*.
2026-03-31: Basis Reported; EBITDA $401,000.00; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $1.61M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $547.00K*; Operating income -$89.00K; Depreciation and amortization $636.00K*.

Complete source-backed ebitda history.

Available history: 2019-03-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$2.11M*	$1.70M	$411.00K*	(m)	(m)	$1.04M*	$6.35M*	(m)	$2.96M	(m)	-$42.35M
2026-03-31	Reported	$401,000.00	(m)	(m)	(m)	1.46%	$167.00K	-$491.00K	(m)	$2.65M	(m)	$62.00K
2025-12-31	Reported	$1.61M	(m)	(m)	(m)	8.56%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$547.00K*	-$89.00K	$636.00K*	(m)	(m)	(m)	$6.10M*	(m)	$2.71M	(m)	$82.00K
2025-06-30	Reported	-$15.45M*	-$16.13M	$674.00K*	(m)	(m)	$1.74M*	$7.37M*	(m)	$1.97M	(m)	$126.00K
2025-03-31	Reported	$183,000.00	(m)	(m)	(m)	0.83%	$175.00K	$1.73M	(m)	$1.44M	(m)	$14.00K
2024-12-31	Reported	$1.48M	(m)	(m)	(m)	9.79%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$989.00K*	-$418.00K	$1.41M*	(m)	(m)	(m)	$4.80M*	(m)	$1.89M	(m)	-$80.00K
2024-06-30	Reported	$146.00K*	-$1.31M	$1.45M*	(m)	(m)	(m)	$6.46M*	(m)	$2.03M	(m)	$1.00K
2024-03-31	Reported	-$1.93M	(m)	(m)	(m)	-10.48%	(m)	-$4.47M	(m)	$2.08M	(m)	$17.00K
2023-12-31	Reported	$19M	(m)	(m)	(m)	-135.93%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$13.55M*	-$15.47M	$1.92M*	(m)	(m)	$1.50M*	-$4.38M*	(m)	$3.74M	(m)	$115.00K
2023-06-30	Reported	-$8.63M*	-$10.63M	$2.00M*	(m)	(m)	$609.00K*	-$7.72M*	(m)	$3.79M	(m)	$2.00K
2023-03-31	Reported	-$11.88M	(m)	(m)	(m)	-31.52%	$3.29M	-$2.71M	(m)	$4.15M	(m)	$92.00K
2022-12-31	Reported	$92.07M	(m)	(m)	(m)	-223.13%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$9.94M*	-$11.74M	$1.80M*	(m)	(m)	$2.45M*	$1.50M*	(m)	$3.42M	(m)	-$599.00K
2022-06-30	Reported	-$74.96M*	-$76.56M	$1.60M*	(m)	(m)	$2.04M*	-$9.92M*	(m)	$3.43M	(m)	-$3.74M
2022-03-31	Reported	-$6.31M	(m)	(m)	(m)	-17.43%	$1.46M	-$7.92M	(m)	$3.78M	(m)	-$599.00K
2021-12-31	Reported	-$16.84M	(m)	(m)	(m)	-45.13%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$10.02M*	-$11.16M	$1.14M*	(m)	(m)	$2.41M*	$2.08M*	(m)	$3.22M	(m)	-$4.99M
2021-06-30	Reported	-$3.44M*	-$4.55M	$1.12M*	(m)	(m)	$2.69M*	-$7.72M*	(m)	$3.04M	(m)	-$12.55M
2021-03-31	Reported	-$204,000.00	(m)	(m)	(m)	-1.21%	$1.72M	$1.82M	(m)	$1.99M	(m)	$0.00
2020-12-31	Reported	-$4.83M	(m)	(m)	(m)	-32.79%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$765.00K*	-$1.25M	$481.00K*	(m)	(m)	$119.00K*	-$502.00K*	$4.83M	$1.73M	(m)	$0.00
2020-06-30	Reported	$604.00K*	$44.00K	$560.00K*	(m)	(m)	$105.00K*	$4.20M*	$4.50M	$1.48M	(m)	$0.00
2020-03-31	Reported	$783,000.00	(m)	(m)	(m)	6.44%	$146.00K	$687.00K	$4.57M	$1.66M	(m)	$0.00
2019-12-31	Reported	-$416,000.00	(m)	(m)	(m)	-5.01%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$608.00K*	-$772.00K	$164.00K*	(m)	(m)	$90.00K*	$1.14M*	$2.09M	$1.03M	(m)	$0.00
2019-06-30	Reported	$858.00K*	$747.00K	$111.00K*	(m)	(m)	$110.00K*	-$67.00K*	$1.97M	$691.00K	(m)	$0.00
2019-03-31	Reported	$664,000.00	(m)	(m)	(m)	11.51%	$156.00K	$1.15M	$1.65M	$359.00K	(m)	$0.00
2018-09-30	Reported	(m)	$1.20M	(m)	(m)	(m)	$278.00K*	$808.00K*	$1.61M	$312.00K	(m)	(m)
2018-06-30	Reported	(m)	$1.28M	(m)	(m)	(m)	$20.00K*	$563.00K*	$1.54M	$325.00K	(m)	(m)
2018-03-31	Reported	(m)	$140.00K	(m)	(m)	(m)	$41.00K	$392.00K	$1.36M	$346.00K	(m)	(m)
2017-09-30	Reported	(m)	-$32.34K	(m)	(m)	(m)	$13.26K*	$74.38K*	$1.10M	$293.09K	(m)	(m)
2017-06-30	Reported	(m)	-$341.20K	(m)	(m)	(m)	$41.03K*	-$102.92K*	$956.84K	$318.61K	(m)	(m)
2017-03-31	Reported	(m)	-$464.04K	(m)	(m)	(m)	$37.15K	-$169.35K	$928.40K	$286.75K	(m)	(m)
2016-09-30	Reported	(m)	-$1.14M	(m)	(m)	(m)	$30.77K*	(m)	$920.93K	$496.87K	(m)	(m)
2016-06-30	Reported	(m)	-$1.59M	(m)	(m)	(m)	$72.42K*	(m)	$872.84K	$599.03K	(m)	(m)
2016-03-31	Reported	(m)	-$1.49M	(m)	(m)	(m)	$26.94K	(m)	$771.00K	$504.24K	(m)	(m)
2015-09-30	Reported	(m)	-$1.30M	(m)	(m)	(m)	$31.85K*	-$1.17M*	$658.54K	$329.53K	(m)	(m)
2015-06-30	Reported	(m)	-$1.16M	(m)	(m)	(m)	$30.88K*	-$1.23M*	$678.11K	$301.33K	(m)	(m)
2015-03-31	Reported	(m)	-$1.16M	(m)	(m)	(m)	$41.13K	-$1.31M	$618.10K	$322.17K	(m)	(m)
2014-09-30	Reported	(m)	-$874.51K	(m)	(m)	(m)	$149.46K*	-$697.90K*	$654.98K	$153.33K	(m)	(m)
2014-06-30	Reported	(m)	-$887.87K	(m)	(m)	(m)	$78.92K*	-$873.52K*	$666.58K	$192.78K	(m)	(m)
2014-03-31	Reported	(m)	-$369.04K	(m)	(m)	(m)	$18.78K	-$894.13K	$1.16M	$167.29K	(m)	(m)
2013-09-30	Reported	(m)	-$110.09K	(m)	(m)	(m)	$9.39K*	-$12.53K*	$1.28M	$160.53K	(m)	(m)
2013-06-30	Reported	(m)	-$82.84K	(m)	(m)	(m)	$191.79K*	$206.47K*	$1.50M	$94.91K	(m)	(m)
2013-03-31	Reported	(m)	$192.33K	(m)	(m)	(m)	$33.94K	-$126.48K	$1.03M	$105.97K	(m)	(m)
2012-09-30	Reported	(m)	-$148.71K	(m)	(m)	(m)	$148.65K*	$121.00*	$1.09M	$110.69K	(m)	(m)
2012-06-30	Reported	(m)	-$306.63K	(m)	(m)	(m)	$976.00K*	$760.83K*	$641.75K	$126.63K	(m)	(m)
2012-03-31	Reported	(m)	-$179.26K	(m)	(m)	(m)	$47.22K	-$74.82K	$346.13K	$116.52K	(m)	(m)
2011-09-30	Reported	(m)	-$284.81K	(m)	(m)	(m)	$14.10K*	-$253.33K*	$345.56K	$98.90K	(m)	(m)
2011-06-30	Reported	(m)	-$260.01K	(m)	(m)	(m)	$29.80K*	-$239.16K*	$288.92K	$133.39K	(m)	(m)
2011-03-31	Reported	(m)	-$454.28K	(m)	(m)	(m)	$13.47K	-$304.64K	$368.60K	$158.79K	(m)	(m)
2010-09-30	Reported	(m)	-$286.20K	(m)	(m)	(m)	-$2.96K*	-$314.63K*	$300.05K	$98.35K	(m)	(m)
2010-06-30	Reported	(m)	-$391.53K	(m)	(m)	(m)	(m)	(m)	$274.15K	$81.50K	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$14.35M	(m)	(m)	(m)	-14.91%	$9.48M	$20.11M	(m)	$7.57M	(m)	$49.00K
2024-12-31	Reported	$683,000.00	(m)	(m)	(m)	0.91%	$3.23M	$8.43M	(m)	$4.75M	(m)	-$38.00K
2023-12-31	Reported	-$10.09M	(m)	(m)	(m)	-14.84%	$6.38M	-$12.50M	(m)	$5.51M	(m)	-$64.00K
2022-12-31	Reported	$852,000.00	(m)	(m)	(m)	1.12%	$10.38M	-$8.49M	(m)	$8.67M	(m)	-$5.24M
2021-12-31	Reported	-$30.5M	(m)	(m)	(m)	-25.59%	$8.38M	-$4.59M	(m)	$11.82M	(m)	-$20.12M
2020-12-31	Reported	-$4.21M	(m)	(m)	(m)	-8.75%	$1.96M	$6.64M	(m)	$6.72M	(m)	-$3.26M
2019-12-31	Reported	$498,000.00	(m)	(m)	(m)	1.82%	$675.00K	$1.21M	$8.76M	$3.17M	(m)	-$1.54M
2018-12-31	Reported	(m)	$3.66M	(m)	(m)	(m)	$500.00K	$2.35M	$6.22M	$1.30M	(m)	(m)
2017-12-31	Reported	(m)	-$1.06M	(m)	(m)	(m)	$144.00K	$605.00K	$4.28M	$1.19M	(m)	$0.00
2016-12-31	Reported	(m)	-$4.85M	(m)	(m)	(m)	$143.53K	-$4.33M	$3.45M	$2.03M	(m)	$0.00
2015-12-31	Reported	(m)	-$5.02M	(m)	(m)	(m)	$134.01K	-$4.97M	$2.63M	$1.38M	(m)	$0.00
2014-12-31	Reported	(m)	-$3.14M	(m)	(m)	(m)	$589.68K	-$3.16M	$3.16M	$871.10K	(m)	$0.00
2013-12-31	Reported	(m)	-$285.36K	(m)	(m)	(m)	$236.67K	$146.01K	$5.19M	$487.82K	(m)	$0.00
2012-12-31	Reported	(m)	-$942.24K	(m)	(m)	(m)	$1.15M	$854.93K	$3.37M	$463.64K	(m)	$0.00
2011-12-31	Reported	(m)	-$1.21M	(m)	(m)	(m)	$93.53K	-$989.92K	$1.36M	$516.45K	(m)	(m)
2010-12-31	Reported	(m)	-$1.39M	(m)	(m)	(m)	$28.41K	-$1.25M	$1.23M	$318.90K	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Axogen, Inc. (AXGN)	United States	$2.329B	-73.83
CONMED Corp (CNMD)	United States	$1.353B	26.72
Ceribell, Inc. (CBLL)	United States	$0.916B	-11.27
TransMedics Group, Inc. (TMDX)	United States	$2.911B	15.17
CapsoVision, Inc (CV)	United States	$0.310B	-12.68
Electromed, Inc. (ELMD)	United States	$0.233B	31.13
EDAP TMS SA (FOCL)		$0.171B
Stereotaxis, Inc. (STXS)	United States	$0.130B	-7.53
Vivani Medical, Inc. (VANI)	United States	$0.111B
electroCore, Inc. (ECOR)	United States	$0.102B